Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’
Researchers still think patients should receive an injectable version of semaglutide when possible, but new data out of ACC.25 confirm that an oral formulation of the drug is associated with significant benefits.
FDA sees promise in new AI model for heart attack detection
Powerful Medical's advanced algorithm was designed to detect STEMI and STEMI-equivalent patterns in a patient’s ECG results.
Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks
When patients require subsequent noncardiac surgery after a major heart operation, waiting at least 100 days is one way to limit the risk of an adverse event. Read the full analysis in JACC: Advances.
Abbott makes IVL move as FDA approves new clinical trial
Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

Diabetes increases risk of death, complications when patients undergo CABG or PCI for left main disease

Researchers also found that CABG and PCI were each associated with their own advantages and disadvantages, highlighting the importance of shared decision-making.

too much niacin, also known as vitamin b3, may increase the risk of adverse cardiovascular events such as heart attacks and strokes.

Too much niacin? Excess vitamin B3 may increase risk of heart attack, stroke

Nutritionists view niacin, also known as vitamin B3, as a fundamental part of any diet. Consuming too much, however, could potentially be bad for the heart.

The HeartBeam AIMIGo device is approximately the size of a credit card and uses the company’s patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthesized 12-lead ECG.

New research underway on credit card-sized heart monitor that synthesizes 12-lead ECGs

The portable device uses HeartBeam's patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthetic 12-lead ECG.

Boston Scientific’s Agent Drug-Coated Balloon (DCB), which delivers a therapeutic dose of the anti-proliferative drug paclitaxel to the patient’s scar tissue to prevent ISR from recurring, gained FDA approval on March 1..

Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing.

$HeartFlow FFR-CT is a non-invasive imaging method to determine the fractional flow reserve for the entire coronary tree.$

AI-based CAD assessments as accurate as FFR, new 10-year study confirms

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

Some older patients taking aspirin to prevent CVD may be doing more harm than good

“Aspirin is no longer a one-size-fits-all preventive tool for older adults," according to one specialist with Michigan Medicine.

Using computed tomography (CT) to perform coronary artery calcium (CAC) scoring can help identify symptomatic chest pain patients who do not require further testing, according to a new analysis published in Radiology.[1]

Coronary calcium scoring predicts when chest pain patients can skip invasive testing

Using CT to perform coronary artery calcium scoring on symptomatic chest pain patients can deliver significant value, according to a new data published in Radiology.

Acute Coronary Syndromes

Plant-based diets may help patients with diabetes, heart disease live longer

Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’

FDA sees promise in new AI model for heart attack detection

Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks

Abbott makes IVL move as FDA approves new clinical trial